VIAP
Price:
$0.0005
Market Cap:
$10.28K
VIA Pharmaceuticals, Inc., a development stage biotechnology company, focuses on the development of compounds for the treatment of cardiovascular and metabolic diseases. It is developing a pipeline of small molecule drugs that target the underlying causes of cardiovascular and metabolic diseases, including vascular inflammation, high cholesterol, high triglycerides, and insulin sensitization/diabetes. The company's drug development pipeline includes VIA-3196, a Phase-1 ready liver-directed thyroid hormone receptor (THR) beta agonist that targets dyslipidemia, such as high LDL cholesterol, high triglycerides, and elevated Lp(a); Diacylglycerol Acyl Transferase 1 (DGAT1) inhibitor, which is in...[Read more]
Industry
Medical - Pharmaceuticals
IPO Date
2007-06-06
Stock Exchange
OTC
Ticker
VIAP
According to VIA Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.05. This represents a change of -77.80% compared to the average of -0.23 of the last 4 quarters.
The mean historical PE Ratio of VIA Pharmaceuticals, Inc. over the last ten years is -0.76. The current -0.05 PE Ratio has changed 562.06% with respect to the historical average. Over the past ten years (40 quarters), VIAP's PE Ratio was at its highest in in the March 2003 quarter at -0.04. The PE Ratio was at its lowest in in the September 2006 quarter at -4.77.
Average
-0.76
Median
-0.18
Minimum
-4.46
Maximum
-0.09
Discovering the peaks and valleys of VIA Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 904.36%
Maximum Annual PE Ratio = -0.09
Minimum Annual Increase = -84.06%
Minimum Annual PE Ratio = -4.46
| Year | PE Ratio | Change |
|---|---|---|
| 2010 | -0.09 | -55.18% |
| 2009 | -0.19 | 9.27% |
| 2008 | -0.17 | -84.06% |
| 2007 | -1.09 | -75.51% |
| 2006 | -4.46 | 904.36% |
| 2005 | -0.44 | -32.13% |
| 2004 | -0.65 | 318.52% |
| 2003 | -0.16 | 6.97% |
| 2002 | -0.15 | -4.98% |
| 2001 | -0.15 | -4.73% |
The current PE Ratio of VIA Pharmaceuticals, Inc. (VIAP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.15
5-year avg
-1.20
10-year avg
-0.76
VIA Pharmaceuticals, Inc.’s PE Ratio is less than OneLife Technologies Corp. (-0.00), less than LifePoint, Inc. (-0.00), less than Healthtech Solutions Inc. (-0.00), less than InNexus Biotechnology, Inc. (-0.00), less than Trevena, Inc. (-0.00), less than iCoreConnect Inc. (-0.00), less than Winston Pharmaceuticals, Inc. (-0.01), less than Acutus Medical, Inc. (-0.00), less than Evelo Biosciences, Inc. (-0.00), greater than Allstar Health Brands, Inc. (-0.08),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.00 | $1.00K | |
| -0.00 | $2.09K | |
| -0.00 | $10.66K | |
| -0.00 | $12.63K | |
| -0.00 | $10.37K | |
| -0.00 | $4.88K | |
| -0.01 | $23.22K | |
| -0.00 | $8.97K | |
| -0.00 | $3.80K | |
| -0.08 | $6.76K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like VIA Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like VIA Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is VIA Pharmaceuticals, Inc.'s PE Ratio?
How is the PE Ratio calculated for VIA Pharmaceuticals, Inc. (VIAP)?
What is the highest PE Ratio for VIA Pharmaceuticals, Inc. (VIAP)?
What is the 3-year average PE Ratio for VIA Pharmaceuticals, Inc. (VIAP)?
What is the 5-year average PE Ratio for VIA Pharmaceuticals, Inc. (VIAP)?
How does the current PE Ratio for VIA Pharmaceuticals, Inc. (VIAP) compare to its historical average?